Pre-treatment levels of cathepsin S were higher in RNA from PBLs of patients classified as ‘good responders’ ( n = 12) compared to the ‘others’ group ( n = 11), shown in Figure 4A ; however, this trend did not reach statistical significance.
← all excerpts
Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis.
1
—
—